We are live on ! Find out more
VCM

Voleon Capital Management Portfolio holdings

AUM $4.64B
1-Year Est. Return 38.78%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+38.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.3B
AUM Growth
-$449M
Cap. Flow
-$455M
Cap. Flow %
-35.04%
Top 10 Hldgs %
45.42%
Holding
260
New
87
Increased
29
Reduced
25
Closed
112

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$73M
2
CRM icon
Salesforce
CRM
+$45.4M
3
BAC icon
Bank of America
BAC
+$41.6M
4
DIS icon
Walt Disney
DIS
+$34.6M
5
PG icon
Procter & Gamble
PG
+$26.4M

Sector Composition

Rank Sector Weight
1 Technology 26.16%
2 Financials 20.36%
3 Healthcare 13.94%
4 Consumer Discretionary 10.63%
5 Communication Services 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DPZ icon
101
Domino's
DPZ
$11.5B
$1.96M 0.15%
+8,000
New +$1.98M
MNDT
102
DELISTED
Mandiant, Inc. Common Stock
MNDT
$1.91M 0.15%
143,000
+52,000
+57% +$738K
SRPT icon
103
Sarepta Therapeutics
SRPT
$1.57B
$1.88M 0.15%
25,000
-9,000
-26% -$1.06M
EQH icon
104
Equitable Holdings
EQH
$13B
$1.86M 0.14%
84,000
-16,000
-16% -$343K
ARW icon
105
Arrow Electronics
ARW
$11.1B
$1.72M 0.13%
+23,000
New +$1.63M
AVY icon
106
Avery Dennison
AVY
$13B
$1.7M 0.13%
15,000
-20,000
-57% -$2.28M
ACAD icon
107
Acadia Pharmaceuticals
ACAD
$4.43B
$1.66M 0.13%
+46,000
New +$1.39M
CRL icon
108
Charles River Laboratories
CRL
$11.2B
$1.59M 0.12%
+12,000
New +$1.61M
ECL icon
109
Ecolab
ECL
$78.1B
$1.58M 0.12%
+8,000
New +$1.6M
EBS icon
110
Emergent Biosolutions
EBS
$373M
$1.57M 0.12%
+30,000
New +$1.4M
DK icon
111
Delek US
DK
$4.16B
$1.56M 0.12%
+43,000
New +$1.58M
ZD icon
112
Ziff Davis
ZD
$1.96B
$1.54M 0.12%
+19,550
New +$1.48M
MMS icon
113
Maximus
MMS
$3.17B
$1.47M 0.11%
+19,000
New +$1.44M
AGCO icon
114
AGCO
AGCO
$7.15B
$1.44M 0.11%
+19,000
New +$1.4M
ZNGA
115
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$1.43M 0.11%
246,000
-762,000
-76% -$4.58M
CARS icon
116
Cars.com
CARS
$662M
$1.43M 0.11%
+159,000
New +$2.15M
MOH icon
117
Molina Healthcare
MOH
$10.2B
$1.43M 0.11%
+13,000
New +$1.68M
EOG icon
118
EOG Resources
EOG
$79.2B
$1.41M 0.11%
19,000
-13,000
-41% -$1.05M
JAZZ icon
119
Jazz Pharmaceuticals
JAZZ
$15.9B
$1.41M 0.11%
+11,000
New +$1.47M
BFAM icon
120
Bright Horizons
BFAM
$3.92B
$1.37M 0.11%
+9,000
New +$1.41M
ZS icon
121
Zscaler
ZS
$24.5B
$1.37M 0.11%
+29,000
New +$2.09M
LH icon
122
Labcorp
LH
$25B
$1.34M 0.1%
+9,312
New +$1.36M
WW
123
DELISTED
WW International
WW
$1.29M 0.1%
+34,000
New +$960K
SCHW
124
Charles Schwab
SCHW
$183B
$1.25M 0.1%
+30,000
New +$1.21M
ALLE icon
125
Allegion
ALLE
$13.4B
$1.24M 0.1%
+12,000
New +$1.22M

Similar funds

Voleon Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Voleon Capital Management held 260 positions worth $1.3B, down 26% from $1.75B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Voleon Capital Management withdrew a net $455M in Q3 2019, closing 112 positions and reducing 25 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $69.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Voleon Capital Management opened a new position in Allergan plc worth $75.4M.

  • Voleon Capital Management's largest Q3 2019 buy was Allergan plc: 448,000 shares worth $75.4M.
  • Voleon Capital Management added most to Bank of America in Q3 2019, an estimated $41.6M increase.
  • Voleon Capital Management's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $59.3M.
  • Voleon Capital Management fully exited Alphabet (Google) Class C in Q3 2019, selling an estimated $69.2M.
  • Voleon Capital Management's ten largest holdings make up 45% of its $1.3B portfolio in Q3 2019.
  • Voleon Capital Management opened 87 new positions and closed 112 in Q3 2019.
  • Voleon Capital Management's portfolio value fell 26% quarter-over-quarter to $1.3B.

Based on Voleon Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.